ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Focus On Climate: The Hottest Week In 100,000 Years

News about the “world’s hottest day” has recently been making headlines. Data released by the United States National Centers for Environmental Prediction show that the average temperature of the Earth’s surface reached a record-breaking 17.01°C on July 3. This means that the global average temperature has reached a new high since data collection began in 1979, exceeding the previous records of 16.92°C established on August 14, 2016 and July 24, 2022 (National Centers for Environmental Prediction). According to Jennifer Francis, a senior researcher at the Woodville Center for Climate Research, this week's global average temperature is likely to be the highest in "at least 100,000 years," which carries significant implications.

Researchers believe that the global community may be experiencing a period of extreme heat, potentially spanning several years, which may be primarily caused by global warming due to the persistent emission of greenhouse gasses (GHGs) by human activities. GHGs are naturally or anthropogenically produced gaseous components of the atmosphere that are capable of absorbing and emitting radiation at particular wavelengths within the spectrum of thermal infrared radiation emitted by the Earth’s surface, atmosphere, and clouds, which contributes to the greenhouse effect. The main culprits of the emission of GHGs are the combustion of coal and the use of gasoline. To alleviate this situation, Haier Biomedical has consistently prioritized the incorporation of energy-saving, emission reduction, and zero greenhouse gas emission measures in its product development and design process, and significant progress has been made in this regard.

Following the ratification of the Montreal Protocol and the Kyoto Protocol, technicians from developed countries have studied and compared the alternatives to freon, a Class I substance according to the Montreal Protocol, and gradually categorized them into two major categories, that is, hydrofluorocarbon (HFC) refrigerants and hydrocarbon (HC) refrigerants. However, HC refrigerants have significantly lower greenhouse effect coefficients associated with global warming compared to HFC refrigerants. As a type of natural refrigerant, HC refrigerants do not contribute to atmospheric pollution, nor do they cause any harm to the ozone layer; therefore, they produce almost no greenhouse effect. Furthermore, HC refrigerants outperform R134 and R22 refrigerants in terms of energy consumption savings by about 15% to 35%

Intelligent Protection of Life Science.jpeg

Haier Biomedical is committed to green dual-carbon development through its efforts to consistently research and develop innovative product solutions, seek breakthroughs in scientific and technological innovation in green transformation, and adopt HC refrigerants in all its products categories, positioning itself as a pioneering force within the framework of the carbon-neutral strategy, and effectively addressing the requirements for the green dual-carbon goal. Following the breakthrough in the key technology of HC refrigeration, Haier Biomedical has further introduced an innovative series of ultra-low-temperature refrigerators with an energy-saving core that can reduce energy consumption by up to 50%. The lowest energy consumption of these units has reached single-digit figures, and each unit reduces carbon emissions by an average of 2.004 tons per year. Haier Biomedical’s R&D team has also overcome the technical challenge of the large-cooling-capacity Stirling refrigerator. This feat is achieved by using helium as the refrigeration medium, which offers a combination of green properties, high efficiency, and large cooling capacity, and has high reliability and an extended lifespan. The company has embarked on a new stage of promoting green and low-carbon development within the industry through the development of ultra-low temperature and other cold chain products and empowering the practices of carbon reduction by technological innovation, consistently leading the industry in green transformation and development.

product overview.jpeg

Haier Biomedical is focused on the development of solar-powered equipment. In 2022, the company generated a total of 1,489,000 kilowatt-hours of electricity through the use of photovoltaic power generation equipment, which is equivalent to a reduction of 865.69 tons of carbon emissions. At the same time, its products and solutions of the solar-powered vaccine refrigerator series can reduce carbon emissions by 109,500 tons annually, which is equivalent to the carbon neutrality achieved by 4,500 acres of mature forest. Haier Biomedical has time and again surpassed its own records, accelerated its industrial deployment, and consistently launched innovative and forward-thinking products, contributing to the global cause of energy-saving and emission reduction.

At present, Haier Biomedical’s products and solutions have presence in over 135 countries and regions around the world. In particular, the export of its solar energy products has promoted technical and cultural exchanges between different countries. In addition, with its mission of “Makes Life Better”, Haier Biomedical is actively building the world’s leading medical and healthcare ecosystem, and strives to achieve the goal of zero greenhouse gas emissions, thereby ensuring the well-being and health of people across the globe.

article source: https://www.haiermedical.com/news/Focus-On-Climate-The-Hottest-Week-In-100000-Years

Media Contact
Company Name: Haier Biomedical
Email: Send Email
Phone: +86-532-88935593
Country: China
Website: https://www.haiermedical.com/


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.